Elevance Health Shareholders Encouraged to Seek Potential Recovery

Law firm Johnson Fistel investigates potential securities law violations by Elevance Health

Published on Mar. 2, 2026

Got story updates? Submit your updates here. ›

Johnson Fistel, PLLP, a national shareholder-rights law firm, is investigating potential claims on behalf of investors of Elevance Health, Inc. (NYSE: ELV) after the company disclosed that the Centers for Medicare & Medicaid Services notified it of intent to impose sanctions suspending enrollment and communications for certain Medicare Advantage-Prescription Drug plans.

Why it matters

The investigation focuses on whether Elevance Health and its executive officers complied with federal securities laws in their disclosures to shareholders. If the investigation finds potential violations, Elevance Health investors who suffered losses may be able to recover those losses.

The details

On February 27, 2026, Elevance Health filed a Form 8-K disclosing that CMS notified the company of its intent to impose intermediate sanctions, including suspending enrollment and communications, on certain of its Medicare Advantage-Prescription Drug plans. These sanctions are scheduled to take effect on March 31, 2026 unless CMS determines the issues have been satisfactorily addressed.

  • On February 27, 2026, Elevance Health filed a Form 8-K disclosing the CMS sanctions.
  • The CMS sanctions are scheduled to take effect on March 31, 2026.

The players

Elevance Health, Inc.

A publicly traded health insurance company that offers Medicare Advantage and other health plans.

Centers for Medicare & Medicaid Services (CMS)

The federal agency that administers the Medicare program and works with states to administer Medicaid.

Johnson Fistel, PLLP

A national shareholder-rights law firm investigating potential securities law violations by Elevance Health.

Got photos? Submit your photos here. ›

What they’re saying

“If you purchased Elevance securities and suffered losses on your investment, join our investigation now.”

— Jim Baker, Attorney (Johnson Fistel, PLLP)

What’s next

The judge will decide on March 31, 2026 whether to allow the CMS sanctions to take effect against Elevance Health.

The takeaway

This investigation highlights the importance of public companies fully complying with securities laws in their disclosures to shareholders, as violations could potentially allow affected investors to recover their losses.